Dextroamphetamine - Amphetamine ER Solicitation
SAM.GOV Due: May 1, 2025 at 07:00 PM UTC
In-Active Presolicitation Source Url

Summary

The Dextroamphetamine - Amphetamine ER Solicitation is a presolicitation opportunity issued by the Defense Logistics Agency (DLA) for the procurement of extended-release formulations of dextroamphetamine and amphetamine. This solicitation is aimed at pharmaceutical manufacturers capable of producing these medications in compliance with federal regulations. Interested contractors should have experience in pharmaceutical manufacturing, particularly in the production of controlled substances, and must be able to meet stringent quality and delivery requirements. The solicitation outlines the necessary compliance with various federal acquisition regulations and emphasizes the importance of therapeutic equivalence and product registration. This opportunity is particularly suited for businesses that specialize in pharmaceutical products and have the capacity to fulfill government contracts.
Description

Solicitation attached.

Entities
DOD
Department of Defense
DLA
Defense Logistics Agency
NAICS
325412
Set Aside
None
Point of Contact
Full Name Email Phone Type
Nancy Fernandez [email protected] 445-737-0713 primary
Jason Wray [email protected] 445-737-6304 secondary
Attachments
  • SPE2D2-25-R-0013+Solicitation+-+Dextro+ER_01.May.2025.pdf